
Firsts
SickKids has been changing the game for paediatric health care since we became the first children’s hospital in Canada in 1875. From groundbreaking research discoveries to world-class clinical innovations and patient and family-centred care, SickKids continues to be a global leader in advancing children's health.
2007
Dr. Stephen Scherer and his team identified copy number variations (CNVs) as a crucial factor in the genetics of autism spectrum disorder.
2008
SickKids is the first in the world to use the NovaLung artificial lung to bridge a paediatric patient to a life-saving lung transplant.
Image: Kate Sutherland, who was temporarily fitted with the artificial lung until receiving a double lung transplant.
2015
SickKids leads a new study that shows how researchers used CRISPR to remove a duplicated gene from a genome for the first time.
2018
SickKids and Toronto Western Hospital use deep brain stimulation on a child with drug-resistant epilepsy for the first time in Canada.
Image: Dr. George Ibrahim, the paediatric neurosurgeon who performed the operation.
2019
SickKids treats Canada's first child with chimeric antibody receptor (CAR) T cells for acute lymphoblastic leukemia following Health Canada approved indication.
2022
A SickKids team delivers the world’s first gene therapy for SPG50, an ultrarare genetic disease. Two years later, the findings show promise in halting the disease’s progression.
2024
SickKids leads a study finding blinatumomab immunotherapy offers improved outcomes for children with B-ALL, the most common childhood cancer. To facilitate this innovative new therapy, SickKids nurses develop a new backpack to administer treatment.
